Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. ABEV
ABEV logo

ABEV Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Ambev SA (ABEV) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Sell
Latest Price
3.070
1 Day change
52 Week Range
3.240
Analysis Updated At
2026/04/16
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Ambev SA (ABEV) is not a good buy for a beginner investor with a long-term focus. The stock is facing significant downward pressure due to weak financial performance, negative analyst sentiment, and hedge fund selling. Additionally, there are no strong technical or proprietary trading signals to suggest a near-term recovery. Given the investor's preferences and the current data, this stock is better avoided at this time.

Technical Analysis

The stock's MACD is slightly positive but contracting, RSI is neutral at 47.271, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). However, the price is below the pivot level of 3.073, indicating weak momentum. Support levels at 2.951 and 2.875 could be tested if the downward trend continues.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

The low Put-Call Ratios indicate a lack of bearish sentiment in the options market, but this is not enough to offset the broader negative sentiment.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
2
Buy
7

Positive Catalysts

  • NULL identified. The options data shows low bearish sentiment, but this is not a strong catalyst.

Neutral/Negative Catalysts

  • Analysts project flat EPS growth by 2026.

Financial Performance

In Q4 2025, revenue dropped by -8.24% YoY, net income fell by -10.94% YoY, EPS decreased by -9.68% YoY, and gross margin declined by -1.96%. These metrics indicate weakening financial performance.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

UBS downgraded the stock to Sell with a price target of $2.65, citing valuation concerns and macroeconomic risks. Barclays raised the price target to $3 but maintained an Equal Weight rating, suggesting limited upside. Analysts are generally cautious or bearish on the stock.

Wall Street analysts forecast ABEV stock price to fall
5 Analyst Rating
Wall Street analysts forecast ABEV stock price to fall
1 Buy
3 Hold
1 Sell
Hold
Current: 3.070
sliders
Low
1.95
Averages
2.77
High
4
Current: 3.070
sliders
Low
1.95
Averages
2.77
High
4
UBS
Neutral -> Sell
downgrade
$2.65
AI Analysis
2026-04-16
Reason
UBS
Price Target
$2.65
AI Analysis
2026-04-16
downgrade
Neutral -> Sell
Reason
UBS downgraded Ambev to Sell from Neutral with a $2.65 price target. The firm believes the stock's risk/reward at current levels is "skewed to the downside" following the 32% rally over the past six months. There is a "growing disconnect" between Ambev's earnings growth profile, Brazil's cost of capital, and valuation, the analyst tells investors in a research note.
Barclays
Equal Weight
maintain
$3
2026-02-17
Reason
Barclays
Price Target
$3
2026-02-17
maintain
Equal Weight
Reason
Barclays raised the firm's price target on Ambev to $3 from $2.50 and keeps an Equal Weight rating on the shares. The company enters 2026 positioned for profitability-led earnings and cash flow growth, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for ABEV
Unlock Now

People Also Watch